米国市場銘柄情報

EPRX Eupraxia Pharmaceuticals Inc

銘柄追加
  • 3.350
  • -0.100-2.90%
終値 11/29 13:00 ET
  • 3.350
  • 0.0000.00%
市場後 17:01 ET
1.19億時価総額-3602直近PER

Eupraxia Pharmaceuticals Inc について

データなし

基本情報

銘柄コードEPRX
会社名Eupraxia Pharmaceuticals Inc
設立日2011
代表者Dr. James A. Helliwell, M.D.
マーケットナスダック
従業員数29
会計年度末12-31
所在地2067 Cadboro Bay Road,Suite 201
都市Victoria
British Columbia
カナダ
郵便番号V8R 5G4
電話番号1-250-590-3968
URLhttp://www.eupraxiapharmaceuticals.com
紹介Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release alternatives to approved drugs. The Company’s principal business is the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidate, EP-104IAR, is designed to meet the unmet medical need and market demand for long-lasting pain relief for knee osteoarthritis (OA). The primary active ingredi

経営陣

  • 名称
  • 役職
  • 年給
  • Dr. James A. Helliwell, M.D.
  • Chief Executive Officer and Director
  • 51.73万
  • Paul Brennan
  • Chief Business Officer
  • 34.31万
  • Bruce G. Cousins
  • Chief Financial Officer and President
  • 36.87万
  • Dr. Mark Kowalski, M.D.,Pd.D
  • Chief Medical Officer
  • 98.88万
  • Dr. Amanda Malone
  • Chief Scientific Officer and Chief Operating Officer
  • 36.87万
  • Dr. Simon Pione, F.R.C.P.C,M.D.,PhD
  • Chairman of the Board
  • 4.22万
  • John S. Montalbano, C.F.A.
  • Independent Director
  • 2.99万
  • Dr. Richard M. Glickman,L.L.D.
  • Independent Director
  • 2.99万
  • Dr. Michael Wilmink, M.D.
  • Independent Director
  • 2.36万
  • Paul L. Geyer, P. Eng.
  • Independent Director
  • 2.36万

分析

アナリスト評価

データなし

今後の予想(目標株価)

データなし

ランキング
米国株
総合人気
コード
現在値
変化率

データなし